# Amkay Products (NSE: AMKAY) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/AMKAY · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹46 Cr, it ranks 3119th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Instruments & Supplies.

Its return on equity was 8.8% in FY26. Promoters held 73.44% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹46 Cr |
| ROE | 8.8% (FY26) |
| ROCE | 13.4% (FY26) |
| Debt to equity | 0.15 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹42 Cr | ₹2 Cr |
| FY25 | ₹38 Cr | ₹3 Cr |
| FY24 | ₹31 Cr | ₹3 Cr |
| FY23 | ₹28 Cr | ₹2 Cr |
| FY22 | ₹37 Cr | ₹1 Cr |
| FY21 | ₹41 Cr | ₹3 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 73.44%
- Non-institutions: 26.56%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Shree Pacetroni](https://app.pivotnow.in/stock/SHREEPAC) | — | ₹50 Cr | — | — |
| [Biofil Chemicals & Pharmaceuticals](https://app.pivotnow.in/stock/BIOFILCHEM) | ₹30.00 | ₹49 Cr | 17.5 | — |
| [Shanmuga Hospit](https://app.pivotnow.in/stock/SHANMUGA) | — | ₹48 Cr | — | — |
| [Mangalam Drugs And Organics](https://app.pivotnow.in/stock/MANGALAM) | ₹29.66 | ₹47 Cr | — | — |
| [Shelter Pharma](https://app.pivotnow.in/stock/SHELTER) | — | ₹46 Cr | — | — |
| [Vista Pharma](https://app.pivotnow.in/stock/VISTAPH) | — | ₹45 Cr | — | — |

## Questions and answers

### What is the market cap of Amkay Products?

Amkay Products' market capitalisation is ₹46 Cr (₹46 Cr) at the 22 Oct 2026 close, ranking 3119th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Amkay Products?

Return on equity was 8.8% in FY26 and return on capital employed was 13.4% in FY26 (standalone figures).

### Is Amkay Products a debt-free company?

No. Amkay Products' debt-to-equity ratio was 0.15 in FY26, with total debt of ₹1 Cr.

### What is the shareholding pattern of Amkay Products?

As of 30 Jun 2026: promoters 73.44%, non-institutions 26.56%.

### Who are Amkay Products' competitors?

The listed Pharma & Healthcare companies closest to Amkay Products by market cap are Shree Pacetroni, Biofil Chemicals & Pharmaceuticals, Shanmuga Hospit, Mangalam Drugs And Organics, Shelter Pharma and Vista Pharma.

### Is Amkay Products a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Amkay Products' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AMKAY against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.